letters & comments

Advance Notice of Proposed Rulemaking: International Price Index Model for Medicare Part B Drugs

12/31/2018 Read More

Centers for Medicare & Medicaid Services’ (CMS’) State Relief and Empowerment Waivers

12/24/2018 Read More

Patient-Focused Drug Development Guidance: Methods To Identify What Is Important to Patients and Select, Develop, or Modify Fit-for-Purpose Clinical Outcome Assessments

12/14/2018 Read More

CMS’s Accountable Care Organizations Pathways to Success

10/16/2018 Read More

FDA Standard Core Clinical Outcome Assessments and Endpoints

10/15/2018 Read More

Letter to Secretary Azar on the Administration’s Step Therapy Policy

09/26/2018 Read More

Proposed Changes to Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs

09/26/2018 Read More

FDA’s Draft Guidance on Patient-Focused Drug Development: Collecting Comprehensive and Representative Input

09/11/2018 Read More

Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs

07/16/2018 Read More
1 2 3 4 5 6 7 8